Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · IEX Real-Time Price · USD
6.63
+0.14 (2.16%)
At close: Jul 2, 2024, 4:00 PM
6.87
+0.24 (3.62%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $411.11 million as of July 2, 2024. Its market cap has decreased by -73.76% in one year.
Market Cap
411.11M
Enterprise Value
370.36M
1-Year Change
-73.76%
Ranking
Category
Stock Price
$6.63
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $411.11M, a decrease of -53.79%. That is a compound annual growth rate of -21.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 402.40M | -48.83% |
| Dec 29, 2023 | 786.40M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.75% |
| Dec 31, 2021 | 991.10M | 11.39% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nano-X Imaging | 411.96M |
| IGM Biosciences | 410.80M |
| Jin Medical International | 407.81M |
| COMPASS Pathways | 405.95M |
| MaxCyte | 402.49M |
| Verve Therapeutics | 401.77M |
| Ocugen | 398.90M |
| AC Immune | 394.81M |